Table 2.
Types of vaccines in clinical trials
Platform | Candidate vaccine number (%) n = 64 |
---|---|
Protein subunit | 19 (30%) |
Inactivated virus | 10 (16%) |
RNA | 7 (11%) |
Viral Vector (replicating) | 4 (6%) |
Virus like particle | 2 (3%) |
Viral vector + Antigen presenting cell | 2 (3%) |
Live attenuated virus | 1 (2%) |
Viral vector + Antigen presenting cell | 1 (2%) |